ACM
AlphaCrest Capital Management’s Charles River Laboratories CRL Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-1,388
| Closed | -$273K | – | 268 |
|
|
2022
Q3 | $273K | Buy |
1,388
+416
| +43% | +$81.8K | 0.02% | 1168 |
|
|
2022
Q2 | $208K | Sell |
972
-1,642
| -63% | -$351K | 0.01% | 1203 |
|
|
2022
Q1 | $742K | Sell |
2,614
-1,757
| -40% | -$499K | 0.04% | 695 |
|
|
2021
Q4 | $1.65M | Buy |
4,371
+3,240
| +286% | +$1.22M | 0.06% | 545 |
|
|
2021
Q3 | $467K | Buy |
+1,131
| New | +$467K | 0.02% | 943 |
|
|
2020
Q3 | – | Sell |
-1,213
| Closed | -$211K | – | 1104 |
|
|
2020
Q2 | $211K | Sell |
1,213
-3,192
| -72% | -$555K | 0.04% | 820 |
|
|
2020
Q1 | $556K | Buy |
4,405
+778
| +21% | +$98.2K | 0.07% | 514 |
|
|
2019
Q4 | $554K | Buy |
+3,627
| New | +$554K | 0.05% | 723 |
|
|
2019
Q1 | – | Sell |
-5,400
| Closed | -$611K | – | 837 |
|
|
2018
Q4 | $611K | Buy |
+5,400
| New | +$611K | 0.18% | 176 |
|